These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33437600)

  • 21. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis.
    Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P
    J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of Adenoviral Titers with Severity of Adenoviral Conjunctivitis and Time to Viral Clearance for 21 Days.
    Morettin CE; Harthan JS; Huecker JB; Perera CD; Than T; Whiteside M; Johnson SD; Shorter E; Migneco MK; Olson CK; Alferez CS; Camp D; Hartwick ATE; Gordon MO
    Optom Vis Sci; 2023 Mar; 100(3):187-193. PubMed ID: 36749104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adenoviral keratoconjunctivitis].
    Renard G
    J Fr Ophtalmol; 2010 Oct; 33(8):586-92. PubMed ID: 20724026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis.
    Aydin Kurna S; Altun A; Oflaz A; Karatay Arsan A
    Acta Ophthalmol; 2015 Jun; 93(4):377-82. PubMed ID: 25043311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a Prospective Randomized Controlled Study.
    Ricciardelli G; Giannaccare G; Di Zazzo A; Coassin M; Scorcia V; Romano MR; Allegrini D; Cennamo M; Antonini M; Bernabei F; Morelli A; Mencucci R
    Eye (Lond); 2022 Jan; 36(1):160-166. PubMed ID: 33654316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance and control of epidemic keratoconjunctivitis.
    Gottsch JD
    Trans Am Ophthalmol Soc; 1996; 94():539-87. PubMed ID: 8981712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
    Schuhman G; Vidic B
    J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan.
    Uemura T; Migita H; Ueno T; Tsukahara-Kawamura T; Saeki Y; Fujimoto T; Uchio E
    Clin Ophthalmol; 2018; 12():511-517. PubMed ID: 29593376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study.
    Trinavarat A; Atchaneeyasakul LO
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):53-8. PubMed ID: 21916618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of clinical signs associated with adenoviral epidemic keratoconjunctivitis cases in southern Japan between 2011 and 2014.
    Aoki K; Gonzalez G; Hinokuma R; Yawata N; Tsutsumi M; Ohno S; Kitaichi N
    Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114885. PubMed ID: 31607514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of Outcomes of Adenoviral Keratoconjunctivitis.
    Lee CS; Lee AY; Akileswaran L; Stroman D; Najafi-Tagol K; Kleiboeker S; Chodosh J; Magaret A; Wald A; Van Gelder RN;
    Ophthalmology; 2018 Sep; 125(9):1344-1353. PubMed ID: 29602567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of adenovirus serotype 8 in patients with Keratoconjunctivitis, in Ahvaz, Iran.
    Shafiei K; Makvandi M; Teimoori A; Samarbafzadeh A; Khataminia G; Jalilian S; Neisi N; Makvandi K; Haj MS
    Iran J Microbiol; 2019 Apr; 11(2):129-136. PubMed ID: 31341567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral keratoconjunctivitis: an update.
    González-López JJ; Morcillo-Laiz R; Muñoz-Negrete FJ
    Arch Soc Esp Oftalmol; 2013 Mar; 88(3):108-15. PubMed ID: 23473088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses.
    Gonzalez G; Yawata N; Aoki K; Kitaichi N
    J Clin Virol; 2019 Mar; 112():1-9. PubMed ID: 30654207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rapid etiologic diagnosis of epidemic keratoconjunctivitis].
    Aoki K; Noto K; Hasegawa I
    Nippon Ganka Gakkai Zasshi; 1990 Aug; 94(8):736-40. PubMed ID: 2239549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and molecular characterization of adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India.
    Gopalkrishna V; Ganorkar NN; Patil PR
    J Med Virol; 2016 Dec; 88(12):2100-2105. PubMed ID: 27152842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The etiology of epidemic keratoconjunctivities (author's transl)].
    Wigand R; Bruch P; Heckenhahn K
    Klin Monbl Augenheilkd; 1975 Dec; 167(6):823-9. PubMed ID: 178946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenoviral keratoconjunctivitis in a tertiary care eye clinic.
    Butt AL; Chodosh J
    Cornea; 2006 Feb; 25(2):199-202. PubMed ID: 16371782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of anti-adenoviral effects of the polyvinyl alcohol iodine ophthalmic solution.
    Tsukahara-Kawamura T; Hanaoka N; Uchio E
    Jpn J Ophthalmol; 2024 Jan; 68(1):64-69. PubMed ID: 37966563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.